PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK)
IDR 2260.0
(-3.42%)
IDR 2260.0
(-3.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 718.02 Billion IDR | 28.9% |
| 2022 | 557.05 Billion IDR | -20.99% |
| 2021 | 705.03 Billion IDR | 68.23% |
| 2020 | 419.1 Billion IDR | 49.53% |
| 2019 | 280.28 Billion IDR | 49.61% |
| 2018 | 187.34 Billion IDR | 67.46% |
| 2017 | 111.87 Billion IDR | 2.9% |
| 2016 | 108.71 Billion IDR | 93.59% |
| 2015 | 56.15 Billion IDR | 131.2% |
| 2014 | 24.29 Billion IDR | -65.09% |
| 2013 | 69.57 Billion IDR | -23.1% |
| 2012 | 90.48 Billion IDR | 14.23% |
| 2011 | 79.2 Billion IDR | 14.9% |
| 2010 | 68.93 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 212.77 Billion IDR | 8.2% |
| 2024 Q1 | 206.64 Billion IDR | 6.41% |
| 2023 Q4 | 194.19 Billion IDR | -9.53% |
| 2023 Q2 | 162.48 Billion IDR | 10.76% |
| 2023 FY | 718.02 Billion IDR | 28.9% |
| 2023 Q3 | 214.63 Billion IDR | 32.09% |
| 2023 Q1 | 146.69 Billion IDR | 1.37% |
| 2022 Q2 | 109.83 Billion IDR | -30.19% |
| 2022 Q4 | 144.72 Billion IDR | -0.31% |
| 2022 FY | 557.05 Billion IDR | -20.99% |
| 2022 Q1 | 157.33 Billion IDR | 86.87% |
| 2022 Q3 | 145.16 Billion IDR | 32.17% |
| 2021 Q1 | 183.7 Billion IDR | 6.22% |
| 2021 FY | 705.03 Billion IDR | 68.23% |
| 2021 Q3 | 220.85 Billion IDR | 2.12% |
| 2021 Q4 | 84.19 Billion IDR | -61.88% |
| 2021 Q2 | 216.27 Billion IDR | 17.73% |
| 2020 Q4 | 172.95 Billion IDR | 55.07% |
| 2020 Q2 | 47.89 Billion IDR | -44.77% |
| 2020 Q3 | 111.53 Billion IDR | 132.89% |
| 2020 Q1 | 86.71 Billion IDR | 81.63% |
| 2020 FY | 419.1 Billion IDR | 49.53% |
| 2019 Q2 | 63.45 Billion IDR | -19.15% |
| 2019 FY | 280.28 Billion IDR | 49.61% |
| 2019 Q3 | 90.6 Billion IDR | 42.79% |
| 2019 Q4 | 47.74 Billion IDR | -47.31% |
| 2019 Q1 | 78.48 Billion IDR | 12.8% |
| 2018 Q3 | 35.63 Billion IDR | -19.74% |
| 2018 Q2 | 44.4 Billion IDR | 17.7% |
| 2018 Q1 | 37.72 Billion IDR | 23.19% |
| 2018 FY | 187.34 Billion IDR | 67.46% |
| 2018 Q4 | 69.57 Billion IDR | 95.22% |
| 2017 Q2 | 23.55 Billion IDR | -20.42% |
| 2017 Q1 | 29.59 Billion IDR | 2.33% |
| 2017 FY | 111.87 Billion IDR | 2.9% |
| 2017 Q4 | 30.62 Billion IDR | 8.98% |
| 2017 Q3 | 28.09 Billion IDR | 19.29% |
| 2016 Q2 | 25.23 Billion IDR | -12.12% |
| 2016 FY | 108.71 Billion IDR | 93.59% |
| 2016 Q4 | 28.92 Billion IDR | 11.88% |
| 2016 Q3 | 25.85 Billion IDR | 2.47% |
| 2016 Q1 | 28.7 Billion IDR | 110.58% |
| 2015 Q3 | 14.07 Billion IDR | -5.66% |
| 2015 Q2 | 14.91 Billion IDR | 10.13% |
| 2015 Q1 | 13.54 Billion IDR | 256.96% |
| 2015 FY | 56.15 Billion IDR | 131.2% |
| 2015 Q4 | 13.63 Billion IDR | -3.1% |
| 2014 Q1 | 13.05 Billion IDR | 418.48% |
| 2014 FY | 24.29 Billion IDR | -65.09% |
| 2014 Q4 | -8.62 Billion IDR | -260.14% |
| 2014 Q3 | 5.38 Billion IDR | -62.78% |
| 2014 Q2 | 14.47 Billion IDR | 10.86% |
| 2013 Q1 | 24.23 Billion IDR | 1.85% |
| 2013 Q2 | 25.21 Billion IDR | 4.08% |
| 2013 Q4 | -4.09 Billion IDR | -116.92% |
| 2013 Q3 | 24.22 Billion IDR | -3.94% |
| 2013 FY | 69.57 Billion IDR | -23.1% |
| 2012 Q2 | 22.07 Billion IDR | 4.62% |
| 2012 Q1 | 21.09 Billion IDR | -5.45% |
| 2012 FY | 90.48 Billion IDR | 14.23% |
| 2012 Q3 | 23.52 Billion IDR | 6.59% |
| 2012 Q4 | 23.78 Billion IDR | 1.13% |
| 2011 Q3 | 19.09 Billion IDR | 3.74% |
| 2011 Q2 | 18.4 Billion IDR | -5.13% |
| 2011 Q4 | 22.31 Billion IDR | 16.88% |
| 2011 FY | 79.2 Billion IDR | 14.9% |
| 2011 Q1 | 19.39 Billion IDR | 0.0% |
| 2010 FY | 68.93 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Bundamedik Tbk | 582.25 Billion IDR | -23.316% |
| PT Metro Healthcare Indonesia Tbk | 89.65 Billion IDR | -700.877% |
| PT Medikaloka Hermina Tbk | 1824.23 Billion IDR | 60.64% |
| PT Mitra Keluarga Karyasehat Tbk | 1968.05 Billion IDR | 63.516% |
| PT Murni Sadar Tbk | 167.6 Billion IDR | -328.401% |
| PT Famon Awal Bros Sedaya Tbk | 515.99 Billion IDR | -39.154% |
| PT Royal Prima Tbk | 75.23 Billion IDR | -854.352% |
| PT Kedoya Adyaraya Tbk | 128.11 Billion IDR | -460.461% |
| PT Sarana Meditama Metropolitan Tbk | 434.04 Billion IDR | -65.426% |
| PT Siloam International Hospitals Tbk | 3644.9 Billion IDR | 80.301% |